ERNA vs MTB · P/E 0.0, rev $582.0K vs P/E 12, $30.99B cap
Eterna Therapeutics Inc (ERNA) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
MTB does not have a complete income-statement cache yet.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the ERNA and MTB stock pages for the full models.
Not investment advice.